ArticleNPJ precision oncology2026
Deep learning-enabled single-cell morpholomic atlas of nasal swabs distinguishes chronic inflammation from sinonasal malignancy.
Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Sinonasal malignancies frequently present with symptoms overlapping chronic inflammatory conditions, complicating early detection and delaying treatment. A fast, non-invasive approach capable of resolving cell states across inflammatory and malignant disease from routine nasal swabs could substantially improve clinical screening. Using the REM-I platform, we generated a reference atlas of deep learning-enabled single-cell morpholomic features from >641K immune cell brightfield images. This reference atlas was integrated with >2.5 M images obtained from nasal swabs spanning health, chronic rhinosinusitis (CRS), and sinonasal carcinoma to perform differential feature testing and comparative feature enrichment across disease states. Sinonasal carcinoma samples exhibited distinct immune remodeling, including increased myeloid-enriched cell abundance and elevated small dark pixel intensity consistent with enhanced granulocyte activity. Basophil/NK-enriched clusters and epithelial clusters contained tumor-associated cells with deep learning-derived morphologic signatures not observed in CRS or healthy samples. These findings support the potential use of nasal swabs in early point-of-care diagnostics.
Identifiers
42332074What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.